AEMD

Aethlon Medical, Inc. NASDAQ Listed Mar 4, 1999

Healthcare ·Medical - Devices ·US · aethlonmedical.com

$2.32

Mkt Cap $1.8M

52w Low $1.36 2.8% of range 52w High $35.20

50d MA $2.13 200d MA $5.28

P/E (TTM) -0.0x

EV/EBITDA 0.0x

P/B 0.1x

Debt/Equity 0.1x

ROE -203.4%

P/FCF -0.6x

RSI (14) —

ATR (14) —

Beta 1.52

50d MA $2.13

200d MA $5.28

Avg Volume 43.0K

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

SIC Code

3841

CIK (SEC)

882291

Phone

619 941 0360

11555 Sorrento Valley Road · San Diego, CA 92121 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 12, 2026	AMC	-2.01	-2.45	-21.9%	1.98	-1.0%	-1.0%	+8.2%	-1.4%	-2.4%	-1.5%	—
Nov 12, 2025	AMC	-1.70	-3.74	-120.0%	4.20	+1.9%	+12.9%	+4.4%	-18.2%	+3.7%	-10.2%	—
Aug 13, 2025	AMC	-6.80	-8.50	-25.0%	12.30	+1.6%	-4.9%	-2.6%	+2.6%	-3.4%	-1.8%	—
Jun 26, 2025	AMC	-0.98	-7.28	-642.9%	19.40	-24.2%	-35.6%	-4.0%	-1.7%	+5.1%	+0.0%	—
Feb 12, 2025	AMC	-0.22	-0.13	+40.9%	53.40	-2.6%	-5.4%	-2.6%	+4.1%	-2.3%	-2.6%	—
Nov 13, 2024	AMC	-0.20	-0.20	+0.0%	32.50	-1.5%	-1.8%	+0.0%	-2.8%	+0.3%	+0.3%	—
Aug 14, 2024	AMC	-0.44	-0.34	+22.7%	30.80	-13.6%	-16.9%	+26.6%	+14.2%	+0.5%	+21.5%	—
Jun 27, 2024	AMC	-1.18	-0.91	+22.9%	46.30	-8.9%	-13.8%	-9.8%	-7.2%	-4.2%	+12.5%	—
Feb 14, 2024	AMC	-1.23	-1.37	-11.4%	138.40	-1.2%	-5.2%	+1.8%	-1.2%	+3.0%	+0.6%	—
Nov 14, 2023	AMC	-1.35	-1.22	+9.6%	132.80	-0.6%	+7.2%	-2.8%	-5.8%	+4.3%	-1.2%	—
Aug 10, 2023	AMC	-1.20	-1.30	-8.3%	280.00	-5.7%	-2.9%	+0.0%	-5.9%	-3.1%	-6.5%	—
Jun 28, 2023	AMC	-1.60	-1.10	+31.2%	336.00	+2.4%	-4.8%	-10.0%	-2.8%	-2.9%	+26.5%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Aug 14	HC Wainwright & Co.	Maintains	Neutral → Neutral	—	$12.30	$12.50	+1.6%	-4.9%	-2.6%	+2.6%	-3.4%	-1.8%
Mar 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$34.90	$35.30	+1.1%	-5.4%	+9.1%	-7.8%	+1.8%	-11.5%
Feb 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$51.20	$50.80	-0.8%	-2.3%	-2.6%	-4.1%	-2.8%	+0.0%
Jan 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$59.30	$58.20	-1.9%	-1.2%	-4.4%	-4.6%	+4.9%	+8.6%
Nov 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$31.90	$30.90	-3.1%	+0.0%	-2.8%	+0.3%	+0.3%	-1.3%
Jun 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$47.90	$46.10	-3.8%	+4.8%	-0.4%	-6.4%	-1.1%	-13.8%
Mar 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$139.20	$139.20	+0.0%	-5.2%	+4.8%	-0.6%	-1.2%	-0.6%
Oct 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$115.20	$113.60	-1.4%	+2.8%	+0.7%	+1.3%	-2.6%	-2.0%
Nov 15	Maxim Group	Downgrade	Buy → Hold	—	$400.00	$400.00	+0.0%	-8.0%	-2.2%	-2.2%	-4.5%	-2.4%
Nov 14	Maxim Group	Downgrade	Buy → Hold	—	$400.00	$400.00	+0.0%	+0.0%	-8.0%	-2.2%	-2.2%	-4.5%
Jun 25	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4264.00	$4112.00	-3.6%	-3.9%	+1.0%	-1.5%	-3.3%	+1.8%
Jun 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4320.00	$4400.00	+1.9%	-1.3%	-3.9%	+1.0%	-1.5%	-3.3%
Jun 1	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1392.00	$1600.00	+14.9%	+34.5%	+0.0%	-1.7%	-3.9%	-0.5%
Jan 8	Maxim Group	Maintains	Buy → Buy	—	$2040.00	$2096.00	+2.7%	+6.3%	+0.4%	-8.1%	+4.0%	+0.8%
Nov 25	H.C. Wainwright	Maintains	Buy → Buy	—	$1240.00	$1352.00	+9.0%	+9.7%	+7.1%	+2.2%	-7.5%	+11.6%
Nov 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$11640.00	$12360.00	+6.2%	+7.2%	+0.0%	+1.0%	+1.9%	-0.9%
Nov 20	H.C. Wainwright	Maintains	Buy → Buy	—	$11640.00	$12360.00	+6.2%	+7.2%	+0.0%	+1.0%	+1.9%	-0.9%

Data updated apr 24, 2026 4:16pm · Source: massive.com